The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.
cancer
electrolytes
metabolism
pH
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Apr 2020
07 Apr 2020
Historique:
received:
02
02
2020
revised:
01
04
2020
accepted:
02
04
2020
entrez:
11
4
2020
pubmed:
11
4
2020
medline:
11
4
2020
Statut:
epublish
Résumé
Cancer cells and tissues have an aberrant regulation of hydrogen ion dynamics driven by a combination of poor vascular perfusion, regional hypoxia, and increased the flux of carbons through fermentative glycolysis. This leads to extracellular acidosis and intracellular alkalinization. Dysregulated pH dynamics influence cancer cell biology, from cell transformation and tumorigenesis to proliferation, local growth, invasion, and metastasis. Moreover, this dysregulated intracellular pH (pHi) drives a metabolic shift to increased aerobic glycolysis and reduced mitochondrial oxidative phosphorylation, referred to as the Warburg effect, or Warburg metabolism, which is a selective feature of cancer. This metabolic reprogramming confers a thermodynamic advantage on cancer cells and tissues by protecting them against oxidative stress, enhancing their resistance to hypoxia, and allowing a rapid conversion of nutrients into biomass to enable cell proliferation. Indeed, most cancers have increased glucose uptake and lactic acid production. Furthermore, cancer cells have very dysregulated electrolyte balances, and in the interaction of the pH dynamics with electrolyte, dynamics is less well known. In this review, we highlight the interconnected roles of dysregulated pH dynamics and electrolytes imbalance in cancer initiation, progression, adaptation, and in determining the programming and reprogramming of tumor cell metabolism.
Identifiants
pubmed: 32272658
pii: cancers12040898
doi: 10.3390/cancers12040898
pmc: PMC7226178
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Cell Sci. 2017 Feb 15;130(4):663-669
pubmed: 28202602
Cancer Res. 2016 Jul 1;76(13):3744-55
pubmed: 27197160
J Membr Biol. 2006;213(1):39-46
pubmed: 17347778
Cancer. 1995 Feb 1;75(3):815-20
pubmed: 7828131
J Environ Pathol Toxicol Oncol. 1996;15(2-4):65-73
pubmed: 9216787
Nat Rev Cancer. 2011 Aug 11;11(9):671-7
pubmed: 21833026
Anticancer Agents Med Chem. 2011 Mar;11(3):307-14
pubmed: 21443504
Cancer Res. 2002 Sep 15;62(18):5381-5
pubmed: 12235011
J Biol Chem. 1995 Mar 17;270(11):6235-42
pubmed: 7890761
Histopathology. 2010 Nov;57(5):744-52
pubmed: 21083604
Biomed Res Int. 2015;2015:409245
pubmed: 25977921
Semin Cancer Biol. 2017 Apr;43:1-4
pubmed: 28249818
J Intern Med. 1990 Oct;228(4):367-71
pubmed: 2125065
Cardiovasc Hematol Disord Drug Targets. 2007 Sep;7(3):188-98
pubmed: 17896959
Evolution. 2015 Jan;69(1):232-44
pubmed: 25346116
Int J Mol Sci. 2019 Feb 11;20(3):
pubmed: 30754643
Mol Cell Proteomics. 2016 Sep;15(9):2924-38
pubmed: 27340238
Mol Carcinog. 2013 May;52(5):329-37
pubmed: 22228080
Cancer Cell. 2013 Apr 15;23(4):464-76
pubmed: 23523103
World Allergy Organ J. 2019 Nov 29;12(11):100077
pubmed: 31871532
J Biol Chem. 1997 May 9;272(19):12575-82
pubmed: 9139710
Physiol Rep. 2018 Jan;6(2):
pubmed: 29368798
Elife. 2015 Mar 20;4:
pubmed: 25793441
J Cancer Res Ther. 2016 Apr-Jun;12(2):892-6
pubmed: 27461670
Oncoscience. 2015 Sep 23;2(10):807-8
pubmed: 26682255
Front Physiol. 2013 Dec 05;4:354
pubmed: 24367336
J Physiol. 1999 Jun 15;517 ( Pt 3):633-42
pubmed: 10358105
FEBS Lett. 2006 May 22;580(12):2850-2
pubmed: 16783874
J Gen Physiol. 1964 May;47:965-74
pubmed: 14155438
Nat Rev Cancer. 2005 Oct;5(10):786-95
pubmed: 16175178
Cell Signal. 2015 Nov;27(11):2139-49
pubmed: 26275497
Biochem Cell Biol. 2002;80(5):499-508
pubmed: 12440691
Cell Death Differ. 2004 Sep;11(9):953-61
pubmed: 15195071
Cancer Lett. 2012 Apr 28;317(2):172-83
pubmed: 22120673
Cancers (Basel). 2011 Jan 20;3(1):408-14
pubmed: 24310355
Mol Pharm. 2011 Dec 5;8(6):2032-8
pubmed: 21981633
Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12465-12468
pubmed: 31298461
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
ScientificWorldJournal. 2001 Dec 12;1:35
pubmed: 30147474
Cancer Res. 2012 Jan 15;72(2):491-502
pubmed: 22135092
Virchows Arch. 2015 Apr;466(4):403-13
pubmed: 25577552
Pflugers Arch. 2014 Apr;466(4):801-10
pubmed: 24449277
Nat Commun. 2014 Apr 01;5:3550
pubmed: 24686499
Cancer Res. 2012 Feb 15;72(4):939-48
pubmed: 22184616
Mol Cell Biochem. 2012 Jun;365(1-2):313-21
pubmed: 22426742
J Cell Biochem. 2012 May;113(5):1692-703
pubmed: 22213537
Exp Physiol. 2003 Jan;88(1):109-19
pubmed: 12525860
Bioessays. 1995 Jun;17(6):491-500
pubmed: 7575490
Neurochem Int. 2018 Jul;117:15-22
pubmed: 29042253
Br J Cancer. 2009 Mar 24;100(6):865-9
pubmed: 19240721
J Biol Chem. 2002 Nov 29;277(48):46408-14
pubmed: 12351627
Oncogene. 2001 Jun 21;20(28):3751-6
pubmed: 11439338
Evol Appl. 2013 Jan;6(1):46-53
pubmed: 23396634
Eur J Cancer. 2005 Dec;41(18):2935-47
pubmed: 16310354
Oncogene. 2008 Oct 27;27(50):6407-18
pubmed: 18955969
J Cell Mol Med. 2004 Apr-Jun;8(2):161-8
pubmed: 15256064
Physiology (Bethesda). 2004 Oct;19:285-92
pubmed: 15381757
Anticancer Agents Med Chem. 2008 Oct;8(7):790-7
pubmed: 18855580
Cancers (Basel). 2019 Jul 20;11(7):
pubmed: 31330859
Proc Jpn Acad Ser B Phys Biol Sci. 2008;84(5):147-54
pubmed: 18941294
FEBS Lett. 2010 May 17;584(10):2076-84
pubmed: 20385134
Eur J Pharmacol. 2005 May 16;515(1-3):20-7
pubmed: 15913603
PLoS One. 2018 Mar 28;13(3):e0193779
pubmed: 29590154
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13
pubmed: 11121063
Cancer Res. 2016 Oct 1;76(19):5845-5856
pubmed: 27488520
Oncotarget. 2014 Nov 30;5(22):11252-68
pubmed: 25361004
J Cell Physiol. 2013 Sep;228(9):1854-62
pubmed: 23459996
Int J Mol Sci. 2019 Sep 01;20(17):
pubmed: 31480530
J Alzheimers Dis. 2010;21(3):939-45
pubmed: 20634585
Cancer Cell Int. 2015 Jul 15;15:71
pubmed: 26180516
Carcinogenesis. 2018 Apr 5;39(4):562-570
pubmed: 29309535
Am J Transl Res. 2018 Nov 15;10(11):3345-3356
pubmed: 30662591
J Clin Pharmacol. 2019 Mar;59(3):350-355
pubmed: 30329162
Neuro Oncol. 2009 Aug;11(4):368-80
pubmed: 19033423
Exp Cell Res. 1971 Dec;69(2):281-8
pubmed: 4360906
Molecules. 2018 Apr 30;23(5):
pubmed: 29710858
FASEB J. 2000 Nov;14(14):2185-97
pubmed: 11053239
Med Oncol. 2015 Jun;32(6):616
pubmed: 25920608
Cancer Res. 2005 Jul 1;65(13):5740-9
pubmed: 15994949
Pharm Pat Anal. 2012 Mar;1(1):91-106
pubmed: 24236716
Int J Oncol. 2016 Jan;48(1):73-83
pubmed: 26718772
Nat Cell Biol. 2000 Jun;2(6):318-25
pubmed: 10854321
Nature. 2015 Jul 2;523(7558):111-4
pubmed: 25985179
Oncol Rep. 2015 Feb;33(2):507-14
pubmed: 25421907
Semin Cancer Biol. 2017 Apr;43:134-138
pubmed: 28122260
Nat Rev Mol Cell Biol. 2008 Jul;9(7):517-31
pubmed: 18568040
Cancer Res. 2011 Nov 15;71(22):6921-5
pubmed: 22084445
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130105
pubmed: 24493753
Cell Rep. 2016 May 10;15(6):1161-74
pubmed: 27134168
J Orthop Res. 2004 Nov;22(6):1175-81
pubmed: 15475194
Cancer Cell. 2015 Jan 12;27(1):57-71
pubmed: 25584894
Adv Physiol Educ. 2004 Dec;28(1-4):160-79
pubmed: 15545345
Chin J Cancer Res. 2013 Dec;25(6):662-70
pubmed: 24385693
Oncotarget. 2015 Oct 13;6(31):31413-27
pubmed: 26429879
Neuroscientist. 2008 Dec;14(6):571-83
pubmed: 18940784
Metabolites. 2018 Feb 28;8(1):
pubmed: 29495652
Science. 2015 Dec 11;350(6266):1391-6
pubmed: 26541605
Mol Biol Cell. 2000 May;11(5):1509-21
pubmed: 10793131
Curr Opin Cell Biol. 2012 Apr;24(2):254-61
pubmed: 22196933
Tumour Biol. 2016 Jul;37(7):9023-35
pubmed: 26762407
Cancer Metab. 2013 Dec 23;1(1):23
pubmed: 24359630
J Membr Biol. 2005 Jun;205(3):115-24
pubmed: 16362499
J Pain Symptom Manage. 2008 Apr;35(4):420-9
pubmed: 18243639
Proteins. 2001 May 1;43(2):175-85
pubmed: 11276087
Cancer Res. 2014 Oct 1;74(19):5507-19
pubmed: 25085245
Science. 2009 Sep 18;325(5947):1555-9
pubmed: 19661383
J Clin Invest. 2008 Dec;118(12):3930-42
pubmed: 19033663
Evid Based Complement Alternat Med. 2013;2013:121725
pubmed: 24454483
J Pharm Pharm Sci. 2014;17(3):439-46
pubmed: 25224353
Nat Rev Cancer. 2013 Sep;13(9):611-23
pubmed: 23969692
J Biol Chem. 2002 Mar 29;277(13):11368-74
pubmed: 11741977
J Physiol Pharmacol. 2008 Dec;59 Suppl 7:71-88
pubmed: 19258658
Anticancer Res. 2013 Sep;33(9):3691-7
pubmed: 24023297
J Cell Biol. 2014 Jul 21;206(2):151-62
pubmed: 25049269
Int J Mol Sci. 2020 Feb 07;21(3):
pubmed: 32046158
Cancer Res. 2011 Apr 1;71(7):2550-60
pubmed: 21300765
Int J Oncol. 2012 Jul;41(1):267-75
pubmed: 22469755
Tumour Biol. 2015 Jan;36(1):193-8
pubmed: 25227665
J Enzyme Inhib Med Chem. 2016 Dec;31(6):859-66
pubmed: 26864256
Cancer Manag Res. 2018 Jun 15;10:1543-1551
pubmed: 29942156
Oncol Rep. 2006 Jan;15(1):49-55
pubmed: 16328033
Carcinogenesis. 2014 Sep;35(9):2014-24
pubmed: 24717311
Anticancer Agents Med Chem. 2017;17(2):164-170
pubmed: 27804847
Perspect Biol Med. 1976 Summer;19(4):509-26
pubmed: 785373
Cancer Res. 2005 Jan 15;65(2):562-71
pubmed: 15695400
Cancer Cell. 2006 May;9(5):351-65
pubmed: 16697956
J Biol Chem. 2001 Nov 30;276(48):44993-5000
pubmed: 11551966
Eur J Pharm Sci. 2007 Jan;30(1):56-63
pubmed: 17125978
J Enzyme Inhib Med Chem. 2019 Dec;34(1):272-278
pubmed: 30734594
Bioimpacts. 2017;7(2):115-133
pubmed: 28752076
Cancers (Basel). 2011 Jul 22;3(3):3002-17
pubmed: 24310356
Mol Cancer. 2015 Apr 15;14:84
pubmed: 25890268
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
J Appl Physiol (1985). 2016 Jan 1;120(1):1-16
pubmed: 26472876
Cancer Lett. 2009 Aug 18;281(1):71-81
pubmed: 19299076
Eur J Pharmacol. 2019 Sep 15;859:172542
pubmed: 31319070
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):654-8
pubmed: 8570610
Semin Cancer Biol. 2017 Apr;43:157-179
pubmed: 28193528
J Transl Med. 2013 Nov 06;11:282
pubmed: 24195657
Recent Pat Anticancer Drug Discov. 2013 Jan 1;8(1):85-99
pubmed: 22738122
Metabolites. 2018 Feb 10;8(1):
pubmed: 29439394
Front Cell Dev Biol. 2019 Aug 07;7:154
pubmed: 31448275
Cell Motil Cytoskeleton. 2009 Aug;66(8):567-87
pubmed: 19363786
Front Physiol. 2014 Apr 16;5:130
pubmed: 24795638
Int J Cancer. 2013 Mar 15;132(6):1288-99
pubmed: 22907202
Assay Drug Dev Technol. 2015 Dec;13(10):650-3
pubmed: 26690767
Nat Commun. 2018 Jul 31;9(1):2997
pubmed: 30065243
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4833-7
pubmed: 6087349
Int J Mol Sci. 2019 Jul 28;20(15):
pubmed: 31357694
Mol Cell. 2013 Aug 22;51(4):531-8
pubmed: 23954348
World J Gastroenterol. 2012 Jun 28;18(24):3070-80
pubmed: 22791942
Gastroenterology. 2019 Sep;157(3):823-837
pubmed: 31078621
Curr Drug Targets. 2014;15(10):988-1000
pubmed: 25198786
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2747-55
pubmed: 25843679
J Biol Chem. 2008 Apr 11;283(15):10162-73
pubmed: 18230611
Cancer Sci. 2017 Jun;108(6):1240-1252
pubmed: 28378944
Metabolites. 2018 Mar 21;8(2):
pubmed: 29561812
Int J Cancer. 2016 Dec 1;139(11):2553-69
pubmed: 27529686
J Physiol. 2015 Dec 15;593(24):5299-312
pubmed: 26486891
Nature. 2016 Sep 22;537(7621):539-543
pubmed: 27626381
Biochim Biophys Acta. 2016 Jun;1863(6 Pt B):1344-50
pubmed: 26608610
Biochim Biophys Acta. 2011 Jun;1807(6):552-61
pubmed: 20955683
Cell Death Differ. 2011 May;18(5):829-40
pubmed: 21127501
Oncogene. 2016 Apr 21;35(16):2112-22
pubmed: 26212013
Brain. 2002 Nov;125(Pt 11):2549-57
pubmed: 12390979
J Gastroenterol Hepatol. 2015 Jan;30(1):208-16
pubmed: 24989236
Eur J Pharmacol. 2009 Dec 25;625(1-3):206-19
pubmed: 19835862
Nat Cell Biol. 2004 Jul;6(7):642-7
pubmed: 15181450
Breast Cancer Res Treat. 2012 Jul;134(2):603-15
pubmed: 22678159
Glia. 2004 Nov 1;48(2):112-9
pubmed: 15378657
PLoS Genet. 2008 Dec;4(12):e1000293
pubmed: 19057672
J Cell Physiol. 2015 Aug;230(8):1954-63
pubmed: 25612232
Int J Mol Med. 2003 Feb;11(2):261-6
pubmed: 12525889
Physiol Rev. 2008 Jul;88(3):1009-86
pubmed: 18626066
FEBS Lett. 2010 May 17;584(10):2102-11
pubmed: 20100480
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):398-400
pubmed: 11209044
Cancer Res Treat. 2016 Jan;48(1):125-32
pubmed: 25761481
Cell Metab. 2014 May 6;19(5):795-809
pubmed: 24726384
BMC Pharmacol Toxicol. 2017 Feb 21;18(1):14
pubmed: 28219421
Science. 2009 Jun 5;324(5932):1289-93
pubmed: 19498162
Biochem Biophys Res Commun. 1990 Oct 15;172(1):328-34
pubmed: 2145837
Front Physiol. 2013 Dec 17;4:370
pubmed: 24381558
Cancers (Basel). 2019 Aug 09;11(8):
pubmed: 31395807
Cancer Res. 2015 Oct 1;75(19):4109-18
pubmed: 26249175
Cell Death Differ. 2006 Sep;13(9):1423-33
pubmed: 16676004
Int J Biochem Cell Biol. 2011 Jul;43(7):950-68
pubmed: 20460169
PLoS One. 2016 Nov 18;11(11):e0166790
pubmed: 27861612
Oncoscience. 2014 Dec 18;1(12):777-802
pubmed: 25621294
F1000Res. 2015 Jul 22;4:297
pubmed: 27408684
Eur J Cell Biol. 2010 Aug;89(8):598-606
pubmed: 20434230
Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35
pubmed: 15961063
Cancer Metastasis Rev. 2019 Jun;38(1-2):5-15
pubmed: 30707328
Breast J. 2020 Mar;26(3):474-478
pubmed: 31478297
Biochem Pharmacol. 2019 May;163:357-361
pubmed: 30826328
Int J Mol Sci. 2018 Apr 19;19(4):
pubmed: 29671777
Acta Pharm Sin B. 2017 Jan;7(1):3-17
pubmed: 28119804
Oncotarget. 2016 Jun 14;7(24):36666-36680
pubmed: 27153561
Expert Opin Ther Pat. 2020 Jan;30(1):15-25
pubmed: 31847622
Curr Oncol. 2011 Jun;18(3):e109-16
pubmed: 21655148
Nat Rev Drug Discov. 2004 May;3(5):391-400
pubmed: 15136787
PLoS One. 2017 Feb 28;12(2):e0172803
pubmed: 28245258
Cell Calcium. 1998 Feb-Mar;23(2-3):173-80
pubmed: 9601613
BMC Cancer. 2014 Apr 23;14:279
pubmed: 24755315
Tumour Biol. 2015 Jun;36(6):4175-9
pubmed: 25582317
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130100
pubmed: 24493748
Cell Rep. 2017 Feb 28;18(9):2228-2242
pubmed: 28249167
Biochem Biophys Res Commun. 2007 Apr 20;355(4):932-6
pubmed: 17321497
Biochim Biophys Acta. 2016 Oct;1863(10):2465-80
pubmed: 26944480
Int J Clin Oncol. 2017 Aug;22(4):651-659
pubmed: 28647837
J Biol Chem. 2002 Jul 19;277(29):26003-11
pubmed: 11978800
J Biol Chem. 2000 Mar 31;275(13):9244-50
pubmed: 10734062
J Membr Biol. 2005 Jun;205(3):159-73
pubmed: 16362504
Physiology (Bethesda). 2011 Aug;26(4):252-65
pubmed: 21841073
Cancer Cell. 2006 Jun;9(6):425-34
pubmed: 16766262
J Exp Clin Cancer Res. 2012 May 11;31:44
pubmed: 22578365
Int J Dev Biol. 2015;59(7-9):357-66
pubmed: 26009234
Front Pharmacol. 2015 Jul 29;6:152
pubmed: 26283962